| Interpretation of T cell states from single-cell transcriptomics data using reference atlases M Andreatta, J Corria-Osorio, S Müller, R Cubas, G Coukos, SJ Carmona Nature communications 12 (1), 2965, 2021 | 280 | 2021 |
| Low-dose radiotherapy reverses tumor immune desertification and resistance to immunotherapy FG Herrera, C Ronet, M Ochoa de Olza, D Barras, I Crespo, M Andreatta, ... Cancer discovery 12 (1), 108-133, 2022 | 224 | 2022 |
| Orthogonal cytokine engineering enables novel synthetic effector states escaping canonical exhaustion in tumor-rejecting CD8+ T cells J Corria-Osorio, SJ Carmona, E Stefanidis, M Andreatta, Y Ortiz-Miranda, ... Nature Immunology 24 (5), 869-883, 2023 | 22 | 2023 |
| Influence of maternal redox status on birth weight JC Osorio, E Cruz, M Milanés, Y Ramírez, M Sierra, M Cruz, L Sanfiel Reproductive toxicology 31 (1), 35-40, 2011 | 22 | 2011 |
| Low-dose radiotherapy reverses tumor immune desertification and resistance to immunotherapy. Cancer Discov. 2022; 12: 108–133. doi: 10.1158/2159-8290 FG Herrera, C Ronet, M Ochoa de Olza, D Barras, I Crespo, M Andreatta, ... CD-21-0003.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 14 | |
| Modulation of CD4 T cell function via CD6-targeting RF Freitas, A Basto, SCP Almeida, RF Santos, CM Gonçalves, ... EBioMedicine 47, 427-435, 2019 | 13 | 2019 |
| PGE2 inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function M Morotti, AJ Grimm, HC Hope, M Arnaud, M Desbuisson, N Rayroux, ... Nature, 1-9, 2024 | 11 | 2024 |
| Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8+ T-myeloid cell networks in melanoma D Barras, E Ghisoni, J Chiffelle, A Orcurto, J Dagher, N Fahr, F Benedetti, ... Science Immunology 9 (92), eadg7995, 2024 | 11 | 2024 |
| Balance entre las especies reactivas y los sistemas antiooxidantes en la gestación normal J Corría Osorio, E Cruz Manzano Revista Cubana de Obstetricia y Ginecología 35 (2), 0-0, 2009 | 10 | 2009 |
| Interpretation of T cell states from single-cell transcriptomics data using reference atlases. Nat. Commun. 12, 2965 M Andreatta, J Corria-Osorio, S Müller, R Cubas, G Coukos, SJ Carmona | 9 | 2021 |
| Evidencias de la regulación del estado redox materno entre las 30 y 36 semanas de gestación E Cruz Manzano, J Corría Osorio, M Milanés Ojea, Y Ramírez Suárez, ... Revista Cubana de Obstetricia y Ginecología 36 (4), 0-0, 2010 | 7 | 2010 |
| Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy. Cancer Discov. 2022; 12 (1): 108-33 FG Herrera, C Ronet, M Ochoa de Olza, D Barras, I Crespo, M Andreatta, ... Epub 2021/09/05. doi: 10.1158/2159-8290. CD-21-0003. PubMed PMID: 34479871, 0 | 7 | |
| Projecting single-cell transcriptomics data onto a reference T cell atlas to interpret immune responses M Andreatta, J Corria-Osorio, S Müller, R Cubas, G Coukos, SJ Carmona bioRxiv, 2020.06. 23.166546, 2020 | 6 | 2020 |
| Tumor-reactive clonotype dynamics underlying clinical response to TIL therapy in melanoma J Chiffelle, D Barras, R Pétremand, A Orcurto, S Bobisse, M Arnaud, ... bioRxiv, 2023.07. 21.544585, 2023 | 4 | 2023 |
| Tumor microenvironment cellular crosstalk predicts response to adoptive TIL therapy in melanoma D Barras, E Ghisoni, J Chiffelle, A Orcurto, J Dagher, N Fahr, F Benedetti, ... bioRxiv, 2022.12. 23.519261, 2022 | 4 | 2022 |
| Maternal oxidant and antioxidant status in the third trimester of gestation and its relation to the birthweight EC Manzano, OE Postigo, JC Osorio, M León Obstert Gynecol: An Int J 2015, 1-10, 2015 | 3 | 2015 |
| Orthogonal Gene Engineering Enables CD8+ T Cells to Control Tumors through a Novel PD-1+TOX-indifferent Synthetic Effector State J Corria-Osorio, SJ Carmona, E Stefanidis, M Andreatta, T Muller, ... bioRxiv, 2022.02. 18.481059, 2022 | 1 | 2022 |
| Cryoablation Does Not Significantly Contribute to Systemic Effector Immune Responses in a Poorly Immunogenic B16F10 Melanoma Model C Yakkala, J Corria-Osorio, L Kandalaft, A Denys, B Koppolu, R Duran Clinical Cancer Research, OF1-OF11, 2024 | | 2024 |
| A NON-CD25-BINDING IL-2 VARIANT FOR THE EXPANSION OR ENGINEERING OF T CELLS THAT CONFER SUPERIOR TUMOR CONTROL YO Miranda, M Masid, CJ Luna, GM Montalvo Bereau, T Muller, ... Human Gene Therapy 34, A21-A22, 2023 | | 2023 |
| Transcriptional reprogramming by IL-2 variant generates metabolically active stem-like T cells M Masid, C Jiménez-Luna, MB GM, T Muller, N Rayroux, E Cribioli, ... | | 2023 |
